Compare Novartis AG (NVS) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Sunrun Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Sunrun Inc trades at $11.46 (market cap $2.73B). The key difference: Novartis AG is far larger — about 106.3× Sunrun Inc's market cap, and Novartis AG pays a 3.17% dividend while Sunrun Inc pays none. Which is the better fit depends on your goals.
| NVS | RUN | |
|---|---|---|
Market Cap | $290.25B | $2.73B |
Sector | Health | Technology |
52-Week High | $168.62 | $21.41 |
52-Week Low | $113.50 | $9.07 |
Enterprise Value | $330.27B | $16.92B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
